Sm. Gardiner et al., Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide, BR J PHARM, 128(8), 1999, pp. 1772-1778
1 To determine the putative contribution of K-ATP-channels to the haemodyna
mic sequelae of endotoxaemia. three experiments were carried out in differe
nt groups of conscious, chronically-instrumented, unrestrained, male Long E
vans rats.
2 Tn the first experiment, pretreatment with the K-ATP-channel antagonist,
glibenclamide, abolished the initial hypotension, but not the renal vasodil
atation caused by LPS infusion. Subsequently, however, in the presence of g
libenclamide and LPS there was a significant increase in mean arterial bloo
d pressure, and a bradycardia, in contrast to the fall in mean arterial blo
od pressure and the tachycardia seen in the presence of vehicle and LPS. Th
e presser and bradycardic changes in the presence of glibenclamide and LPS
were accompanied by significant reductions in hindquarters flow and vascula
r conductance, and these were significantly greater than those seen in the
presence of vehicle and LPS, or glibenclamide and saline.
3 Administration of glibenclamide 6 h after the onset of saline and LPS inf
usion, or 6 h after the onset of saline and LPS infusion in the presence of
the AT(1)-receptor antagonist, losartan, and the ETA-, ETB- receptor antag
onist, SE 209670, in the absence or presence of dexamethasone, caused a sig
nificant increase in mean arterial blood pressure and reductions in renal,
mesenteric and hindquarters conductances, although the latter was the only
vascular bed in which there was a reduction in flow.
4 The results are consistent with a contribution from K-ATP-channels to the
vasodilatation caused by LPS, particularly in the hindquarters vascular be
d.